Revenue: As of FY2025 Q3, the actual value is USD 0.EPS: As of FY2025 Q3, the actual value is USD 0.EBIT: As of FY2025 Q3, the actual value is USD -88.19 K.<h3>Segment Revenue</h3><ul><li>No revenue was recorded for the three months ended September 30, 2025, compared to $2,500 for the same period in 2024.</li></ul><h3>Operational Metrics</h3><ul><li>Net Loss: The net loss attributable to common stockholders for the three months ended September 30, 2025 was - $438,889, compared to - $126,199 for the same period in 2024.</li><li>Operating Expenses: Operating expenses for the three months ended September 30, 2025 were $100,033, compared to $155,831 for the same period in 2024.</li><li>Net Loss for Nine Months: The net loss attributable to common stockholders for the nine months ended September 30, 2025 was - $669,613, compared to - $773,580 for the same period in 2024.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Used in Operating Activities: For the nine months ended September 30, 2025, net cash used in operating activities was - $159,135, compared to - $15,063 for the same period in 2024.</li><li>Net Cash Provided by Financing Activities: For the nine months ended September 30, 2025, net cash provided by financing activities was $135,820, compared to $17,600 for the same period in 2024.</li></ul><h3>Unique Metrics</h3><ul><li>Derivative Liabilities: The derivative liability was $1,073,416 as of September 30, 2025, compared to $758,787 as of December 31, 2024.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company is focusing on its Structural Health Monitoring (SHM) vertical as the foundation for future revenue streams, despite the suspension of the DOT Bridge Monitoring Contract.</li><li>Non-Core Business: The company is exploring potential mergers or acquisitions due to challenges in raising adequate funds for operations.</li><li>Priority: The company aims to leverage its strategic partnership with Aingura IIoT, S.L. to enhance its capabilities and explore additional U.S. collaborations.</li></ul>

IIOT-OXYS, Inc. | 10-Q: FY2025 Q3 Revenue: USD 0